These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32355346)

  • 1. Composition of unapproved cannabinoid products directly marketed to Canadian pet owners.
    Chicoine A; Vuong S; Illing K; Hare J; Caldwell J; Sandler I
    Can Vet J; 2020 May; 61(5):477-480. PubMed ID: 32355346
    [No Abstract]   [Full Text] [Related]  

  • 2. Danish dog owners' use and the perceived effect of unlicensed cannabis products in dogs.
    Holst P; Kristensen AT; Arendt ML
    PLoS One; 2024; 19(1):e0296698. PubMed ID: 38295012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal.
    Bahji A
    Can J Psychiatry; 2021 Jun; 66(6):586-587. PubMed ID: 33998318
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints.
    Fitzcharles MA; Ste-Marie PA; Clauw DJ; Jamal S; Karsh J; LeClercq S; McDougall JJ; Shir Y; Shojania K; Walsh Z
    BMC Musculoskelet Disord; 2014 Jul; 15():258. PubMed ID: 25080153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?
    Tibbo PG; McKee KA; Meyer JH; Crocker CE; Aitchison KJ; Lam RW; Crockford DN
    Can J Psychiatry; 2021 Feb; 66(2):185-194. PubMed ID: 32911977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and the placenta: Receptors, signaling and outcomes.
    Rokeby ACE; Natale BV; Natale DRC
    Placenta; 2023 Apr; 135():51-61. PubMed ID: 36965349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety issues concerning the medical use of cannabis and cannabinoids.
    Ware MA; Tawfik VL
    Pain Res Manag; 2005; 10 Suppl A():31A-7A. PubMed ID: 16237480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
    Ti L; Tobias S; Maghsoudi N; Milloy MJ; McDonald K; Shapiro A; Beriault D; Stefan C; Lysyshyn M; Werb D
    Drug Alcohol Rev; 2021 May; 40(4):580-585. PubMed ID: 33354869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey.
    Collister D; Tennankore K; Davison SN; Wald R; Rabbat C; Walsh M
    J Pain Symptom Manage; 2021 Feb; 61(2):237-245.e2. PubMed ID: 32805405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.
    An D; Peigneur S; Hendrickx LA; Tytgat J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial, temporal, and space-time clusters associated with opioid and cannabis poisoning events in U.S. dogs (2005-2014).
    Howard-Azzeh M; Pearl DL; Berke O; O'Sullivan TL
    PLoS One; 2022; 17(4):e0266883. PubMed ID: 35482776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids Activate Monoaminergic Signaling to Modulate Key
    Oakes MD; Law WJ; Clark T; Bamber BA; Komuniecki R
    J Neurosci; 2017 Mar; 37(11):2859-2869. PubMed ID: 28188220
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic cannabinoid use: recognition and management.
    Castellanos D; Thornton G
    J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian dog owners' use and perceptions of cannabis products.
    Kogan LR; Hellyer PW; Silcox S; Schoenfeld-Tacher R
    Can Vet J; 2019 Jul; 60(7):749-755. PubMed ID: 31281193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating a predictive model of cannabinoid inheritance with feral, clinical, and industrial Cannabis sativa.
    Wenger JP; Dabney CJ; ElSohly MA; Chandra S; Radwan MM; Majumdar CG; Weiblen GD
    Am J Bot; 2020 Oct; 107(10):1423-1432. PubMed ID: 33103246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions and opinions of Canadian pet owners about anaesthesia, pain and surgery in small animals.
    Steagall PV; Monteiro BP; Ruel HLM; Beauchamp G; Luca G; Berry J; Little S; Stiles E; Hamilton S; Pang D
    J Small Anim Pract; 2017 Jul; 58(7):380-388. PubMed ID: 28390181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid-based medicines for neurological disorders--clinical evidence.
    Wright S
    Mol Neurobiol; 2007 Aug; 36(1):129-36. PubMed ID: 17952657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting binding between 55 cannabinoids and 4,799 biological targets by in silico methods.
    Santillo MF; Sprando RL
    J Appl Toxicol; 2023 Oct; 43(10):1476-1487. PubMed ID: 37101313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
    Tomiyama K; Funada M
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.